AlphaLife Sciences

Private

New JerseyHealthcare & Life Scienceshttps://alphalifesci.com/

Last Round

Accelerator

Sep 28, 2023

Company Overview

AlphaLife Sciences is a software company that provides a GenAI-powered platform to automate the clinical research process for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, RegTech, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

regulatory documentation automationmedical writing automationGenAI platformAI for life sciencesPharma AIAI copilotclinical research automationdrug development softwareRegTechregulatory submissionsCRO softwareVeeva integrationGxP compliance21 CFR Part 11AI authoring services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlphaLife Sciences Comparables

Compare AlphaLife Sciences with similar companies based on industry and business-model similarity.

AlphaLife Sciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Artos	88%
Narrativa	86%
Yseop	84%

View all Comparables

AlphaLife Sciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 28, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Gavin Zhang

Co-Founder & Chief Business Officer

Founding Team

Sharon Chen

Founder And CEO

Founding Team

Bogong Zhu

Chief Product Officer

Executive Team

AlphaLife Sciences Investors

Notable investors and investment history

AlphaLife Sciences investors
Investor	Rounds
B Capital Group	VC Round
Hankang Capital	VC Round
Johnson & Johnson Innovation - JLABS	Accelerator
Nvidia Inception	Accelerator
Microsoft for Startups Pegasus Program	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 22, 2026
Grew 32% QoQ, from 22 to 29 employees.
Jan 1, 2026
Monthly visitors grew 104% MoM, reaching 5.1K.

View all signals

AlphaLife Sciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AlphaLife Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlphaLife Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey

Employee Range28

Year Founded2020

Last FundingSep 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.